Search
News
Important Only
Capricor Therapeutics Q1 net loss widens as expenses rise
OverviewUS biotechnology firm's Q1 2026 saw no revenue and net loss widened year-over-yearCompany's lead therapy Deramiocel under FDA review with PDUFA target date August 2026Cash position expected to fund operations into Q4 2027, excluding potential product salesOutlookCompany expects FDA d...Reuters
Tue, May 12
South Korea's DoubleDown Q1 revenue rises 13%, slightly misses estimates
OverviewSouth Korea digital games developer's Q1 revenue rose 12.7% yr/yr, slightly missed analyst expectationsAdjusted EBITDA for Q1 increased 24% and beat analyst expectationsCompany's Q1 results driven by WHOW Games acquisition and SuprNation brand launchOutlookCompany did not provide spe...Reuters
Tue, May 12
Smart Sand Q1 revenue rises on higher volumes, prices; costs hit bottom line
OverviewU.S. frac sand supplier's Q1 revenue rose 42% yr/yr on higher sales volumes and pricesCompany posted Q1 net loss of $3.9 mln, adjusted EBITDA was $3.8 mlnSmart Sand repurchased $1.4 mln in shares and paid $0.10 special dividend in Q1OutlookCompany expects 2026 sales volume growth of 5% t...Reuters
Tue, May 12
MaxCyte Q1 revenue falls
OverviewUS cell-engineering platform's Q1 revenue fell 7% yr/yr, driven by lower core revenueNet loss for Q1 narrowed compared to prior yearCompany authorized $10 mln share repurchase programOutlookMaxCyte reiterates 2026 revenue guidance of $30 mln to $32 mlnCompany expects 2026 core revenue of...Reuters
Tue, May 12
I3 Verticals Approves New Share Repurchase Program For Up To $100 Million Of Class A Common Stock - SEC Filing
May 12 (Reuters) - I3 Verticals Inc IIIV.O:I3 VERTICALS INC - APPROVES NEW SHARE REPURCHASE PROGRAM FOR UP TO $100 MILLION OF CLASS A COMMON STOCK - SEC FILINGSource text: [ID:n0001728688-26-000034]Reuters
Tue, May 12
Rezolute Q3 net loss narrows as R&D expenses fall
OverviewUS rare disease drug developer's fiscal Q3 net loss narrowed yr/yrR&D expenses fell due to lower manufacturing and clinical trial costsCompany advanced clinical programs for congenital and tumor hyperinsulinismOutlookRezolute expects an update on its congenital HI program in the seco...Reuters
Tue, May 12
US social media legislation gains momentum as key Republican senator pledges support
By Courtney RozenWASHINGTON, May 12 (Reuters) - U.S. legislation that would require social media companies to take more responsibility for how their apps affect children and teens overcame a key hurdle on Tuesday, when a leading Republican senator said he would back the bill.U.S. Senator Ted Cruz sa...Reuters
Tue, May 12
Nextpower Q4 revenue beats estimates, raises 2027 outlook
OverviewUS solar power systems provider's Q4 revenue beat analyst expectations, despite yr/yr declineAdjusted diluted EPS for Q4 fell yr/yrCompany raised FY27 outlook, citing strong execution and bookingsOutlookNextpower raises FY27 revenue outlook to $3.8-$4.1 bln from $3.6-$3.8 blnCompany expe...Reuters
Tue, May 12
Evolv Technologies Q1 revenue jump tops estimates; hikes FY sales view
OverviewSecurity tech firm's Q1 2026 revenue rose 45% yr/yr, beating analyst expectationsAdjusted EBITDA for Q1 2026 improved to $3.9 mln with margin of 8.5%Company raised 2026 revenue outlook, now expects 20%-23% yr/yr revenue growthOutlookEvolv raises 2026 revenue outlook to $175-$180 mln, up ...Reuters
Tue, May 12
HireQuest Q1 revenue falls on asset divestiture
OverviewU.S. staffing franchisor's Q1 revenue fell 13% yr/yr due to MRINetwork asset divestitureAdjusted net income per share was unchanged from prior year at $0.13Adjusted EBITDA declined slightly from Q1 2025OutlookHireQuest says it is positioned to benefit from a stabilizing job marketCompany...Reuters
Tue, May 12
Karman Holdings Q1 revenue slightly beats estimates
OverviewU.S. space and defense systems maker's fiscal Q1 revenue rose 51% yr/yr, slightly beating analyst expectationsAdjusted EPS for fiscal Q1 more than doubled yr/yr, driven by growth across all end marketsOutlookKarman raises 2026 revenue outlook to $720 mln-$735 mlnCompany expects 2026 adju...Reuters
Tue, May 12
Relmada Therapeutics Q1 net loss widens, cash rises
OverviewUS biotech reported Q1 net loss widened to $19.1 mln, EPS at -$0.22Company ended Q1 with $234 mln in cash and investments after $150 mln private placementR&D expenses fell yr/yr due to non-recurring 2025 costs, G&A expenses increasedOutlookRelmada expects to file NDV-01 IND and start...Reuters
Tue, May 12
Hyperfine Q1 revenue rises as commercial engine accelerates
OverviewUS health tech firm's Q1 revenue grew 83% yr/yr, beating analyst expectationsCompany's net loss narrowed compared to prior yr, with improved gross marginCompany bolstered balance sheet with $15 mln debt financing, extending cash runway into 2028OutlookCompany continues to expect 2026...Reuters
Tue, May 12
Paysign beats Q1 revenue estimates on patient affordability programs
OverviewUS patient affordability platform's Q1 revenue rose 51% yr/yr, beating analyst expectationsAdjusted EPS for Q1 rose to $0.09, more than doubling from prior yearGrowth driven by pharma patient affordability and plasma donor compensation programsOutlookPaysign sees Q2 revenue of $26.2 mln–...Reuters
Tue, May 12
Electromed Q3 revenue hits record, beating estimates driven by strong homecare market
OverviewU.S. airway clearance device maker's fiscal Q3 revenue rose 18.4%, beating analyst expectationsNet income for fiscal Q3 rose 59% and beat analyst expectationsGrowth driven by higher sales rep productivity and increased homecare market demandOutlookElectromed says it is confident in susta...Reuters
Tue, May 12
AudioEye's Q1 revenue rises 8%, net loss widens on litigation costs
OverviewUS digital accessibility firm's Q1 revenue rose 8% yr/yr to record highAdjusted EPS for Q1 increased to $0.18 from $0.15 a year agoNet loss widened due to higher litigation expensesOutlookAudioEye expects Q2 2026 revenue between $10.65 mln and $10.75 mlnCompany sees full-year 2026 revenu...Reuters
Tue, May 12
Velo3D Q1 revenue rises on higher 3D printer and parts sales
OverviewMetal 3D printing firm's preliminary Q1 revenue rose 48% yr/yrGross margin improved to 17.2% from 7.5% in prior yr qtrCompany closed $50 mln equity offering in April to fund expansionOutlookVelo3D reaffirms 2026 revenue outlook of $60 mln to $70 mlnCompany expects gross margin above 30% ...Reuters
Tue, May 12
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
OverviewT-cell immunotherapy firm's Q1 revenue fell sharply due to prior-year one-time revenue eventCompany posted Q1 net loss, reversing prior-year profitOperating expenses declined significantly after 2025 cost-reduction moves; cash runway extends into mid-2027OutlookOperating expenses expecte...Reuters
Tue, May 12
GrowGeneration Q1 revenue beats estimates on strength in B2B division
OverviewUS cultivation supply firm's Q1 revenue rose 7.5% yr/yr, beating analyst expectationsNet loss narrowed to $4.9 mln from $9.4 mln, reflecting cost reduction effortsCompany reaffirmed 2026 outlook for revenue and breakeven adjusted EBITDAOutlookGrowGeneration reaffirms 2026 revenue outlook...Reuters
Tue, May 12
Featured Tools
Top News
April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide
Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today
Kospi Plunges Over 5% After Nearing 8,000 Points as South Korean Top Official Proposes ‘AI Profit Redistribution’
Samsung’s Largest Strike in History: Can SK Hynix and Micron Sit Back and Reap the Benefits?
Market Movers
CVS Health Corp Stock (CVS) Closed Up by 3.10% on May 13: Facts Behind the Movement
14 hours ago
CVS
--
Booking Holdings Inc Stock (BKNG) Closed Down by 3.45% on May 13: What Investors Need To Know
14 hours ago
BKNG
--
CrowdStrike Holdings Inc Stock (CRWD) Closed Up by 3.02% on May 13: What Signal Does It Send?
14 hours ago
CRWD
--
Tradingkey
